Weight loss Rx online. See if you qualify

Wegovy® prescribed online for weight loss

(semaglutide) injection

  • Lose 15% of your body weight on average in 1 year*
  • Helps you feel full faster, longer
  • Genuine, FDA-approved treatment

Wegovy is a brand-name version of the generic medication semaglutide, which is a type of medication called a glucagon-like peptide 1 receptor agonist. Instead of that tongue-twister of a name, we call these medications “GLP-1s” for short.

Wegovy is FDA-approved and clinically proven to help with weight loss. How? It acts like a natural hormone your body uses to regulate blood sugar and appetite—key steps in resetting your biological set point to help you maintain a new, lower weight. In fact, the STEP 4 clinical trial saw people who combined Wegovy with lifestyle changes lose an average of 10.6% of their body weight after 20 weeks, and 17% after 68 weeks. Learn more about Wegovy and weight loss.

Wegovy works by mimicking the hormone GLP-1, which slows digestion and helps your brain regulate appetite by reducing hunger sensations. As your digestion slows, you may feel full longer and therefore eat less, which can lead to weight loss.

Our partners will work directly with your insurance provider to help with the process of determining coverage for your GLP-1 medication, which is paid for separately from the Body Program. Ro does not accept insurance for the Body Program, which is cash pay only.

At this time, those with any form of government healthcare coverage (including programs such as Medicare, Medicare Supplement Plans, Medicaid or TRICARE), whether primary or secondary coverage are not eligible for the Body Program. These plans typically do not cover the type of medication the Body Program may prescribe. Unfortunately, this means that those on Medicare or eligible for Medicare cannot join the Body Program. Federal employees who receive their health insurance through the Federal Employee Health Benefits Program (FEHB) may participate in the Body Program.

*In clinical trials studying Saxenda and Wegovy for obesity (BMI ≥30) and overweight (BMI ≥27) with at least one weight-related condition, non-diabetics who completed the trials lost an average of 9% and 15% of their body weight, respectively, when paired with diet and exercise (compared to 3.5% and 2.4% on diet and exercise alone). Some patients may start on Saxenda and then switch to Wegovy if accessible and clinically appropriate.

Safety info: GLP-1 medications are used to treat obesity or overweight (with weight-related problems), along with diet and exercise. They may have serious side effects, including possible thyroid tumors. Do not use if you or your family have a history of a type of thyroid cancer called MTC or MEN 2. See more serious warnings & safety info

There’s a reason everyone is talking about Wegovy. It works!

On average, people on Wegovy lose 15% of their weight in a year*.

Select your current weight

252lbs

Weight you could lose (lbs):

37lbs

*In a 56 and 68 week clinical trial studying two GLP-1 medications for obesity (BMI ≥30) and overweight (BMI ≥27) with at least one weight-related condition, non-diabetics who completed the trials lost an average of 9 and 15% of their body weight when paired with diet and exercise (compared to 3.5% and 2.4%, respectively, on diet and exercise alone).

  • Which GLP-1 is right for you?

    Semaglutide injection was first approved under the brand name Ozempic in 2017 as a treatment for type 2 diabetes. In 2021, the FDA approved the drug at a different dosage under the brand name Wegovy as a weight loss medication. Doctors often, using their medical judgment and discretion, prescribe both for weight loss. Liraglutide injection was FDA approved for weight loss in 2014 under the brand name Saxenda.

    All three medications are GLP-1s, but there are some key differences between them.

    Learn more

  • Is using medication to lose weight cheating?

  • Learn more about potential side effects

    Your Ro-affiliated provider will walk you through the side effects patients report most often:

    • Nausea

    • Vomiting

    • Upset stomach

    • Stomach pains

    • Constipation

    • Diarrhea

    Learn more about Wegovy, Saxenda, and Ozempic.

How Ro helps you lose weight

Getting started

Today

Answer health questions and complete your online visit

Share your health history and weight loss goals with us online to get started.

A Ro-affiliated provider will review your answers and get back to you within a few days.

If you’re a good fit for the program, your provider will order a metabolic lab test. The test will help you understand how your body’s working right now. 

You can use your insurance to test at any Quest location (most insurance accepted), or purchase an at-home blood collection kit through Ro for an additional cost.

If you live in a state where Quest is not available, we’ll automatically send you an at home collection kit for no charge.

After reviewing your results, your provider will determine if you’re eligible for medication. If you are, they’ll tailor a program with prescription treatment best suited to your unique biology.

Ongoing care $145/mo

If you move forward with treatment, our partner pharmacy will ship out your medication, and you’ll have your first dose in 1–3 weeks.

You’ll have everything you need during treatment, including on-demand provider access, medication management, and ongoing refill support.

Before
After

Dr. Pepper lost 30 lbs in 1 year

“I started losing weight almost immediately. To me, truly, this has been a game-changer.”

Dr. Pepper Ro Ambassador who inspired the Body Program, after taking GLP-1 medication

Before
After

Mary lost 40 lbs in 11 months

“I have never felt better. I have never had more energy. This medication changed my life.”

Mary Ro Ambassador who inspired the Body Program, after taking GLP-1 medication

Meet our expert

From diagnosis to delivery, our healthcare providers are with patients every step of the way.

Hear from Body Program members

Ro Body Program members taking branded GLP-1 medications were paid for their testimonials.

  • Sonia

    Ro member

    “I’ve had some pretty amazing success. I’m down 15 pounds and I couldn’t be happier."

  • James

    Ro member

    “It's really helping handle my cravings better, which is what I really like about this program."

  • Chaleeta

    Ro member

    “It was like a switch once I started the medication, I just wasn’t so obsessed with food.”



Questions we hear every day

The cost of Wegovy can range depending on your insurance coverage—and we’re here to help!

Our partners will work directly with your insurance provider to help with the process of determining coverage for your GLP-1 medication, which is paid for separately from the Body Program. Ro does not accept insurance for the Body Program, which is cash pay only. At this time, those with any form of government healthcare coverage (including programs such as Medicare, Medicare Supplement Plans, Medicaid or TRICARE), whether primary or secondary, are not eligible for the Ro Body Program. These plans typically do not cover the type of medication the Ro Body Program may prescribe. Unfortunately, this means that those on Medicare or eligible for Medicare cannot join the Ro Body Program.

Due to significant demand, Novo Nordisk — the manufacturer of Wegovy, Ozempic, and Saxenda — expects supply shortages of some of these medications. Novo Nordisk is anticipating that demand for Wegovy will continue to outpace supply. Patients may have difficulty filling Wegovy prescriptions at the lower doses of 0.25 mg, 0.5 mg, and 1 mg and Saxenda prescriptions through the remainder of 2023 and potentially beyond. We’ve seen that around half of patients are still unable to get access to the impacted Wegovy doses or Saxenda doses after 1 month of waiting.

Ro and Ro-affiliated providers are taking additional steps to support new and existing patients on their weight loss journeys. If you’re prescribed a GLP-1 medication and there’s more than a 30-day delay from the time your prescription is sent to the pharmacy to when it is filled, we’ll issue a credit to your account so that your next month of the Body Program is free. Read eligibility requirements here.

For patients who are prescribed Wegovy or Saxenda and are on their pharmacy's waitlist, our concierge is contacting your pharmacy periodically to check on the status of your prescription.

A provider may also make adjustments to a treatment plan for a patient on Wegovy or Saxenda if they determine it’s clinically appropriate. These adjustments may include prescribing alternate GLP-1 medications (if appropriate), working with you to create a personalized treatment plan, or recommending adjustments to diet, lifestyle, and current fitness activities.

For patients just getting started, the first steps in the Body Program are unaffected by the supply shortages — including taking a metabolic lab test and connecting with a provider to review their health history. If a provider ultimately determines Wegovy or Saxenda is a good fit, the sooner a patient joins the program, the sooner our team can get to work trying to find medication in stock at a pharmacy nearby.

Metabolic testing is required to participate in the program. It allows your provider to understand your metabolism to create a treatment plan that’s appropriate for you. Your provider will look at the following analytes: Hemoglobin, TSH, LDL Cholesterol, HDL Cholesterol, Total Cholesterol, Blood Urea Nitrogen (BUN), Creatinine, and Triglycerides.

Depending on how you choose to take your metabolic test, the price will vary.

You can use your insurance to test at any Quest location. Quest is in-network with most major insurers, but out-of-pocket costs will vary based on your insurance plan and deductible. Contact your insurance company to understand your coverage. If you test at Quest without using your insurance, the cash pay price is around $520.

You can also purchase an at-home blood collection kit through Ro for $75.

If you live in a state where Quest is not available (ND, SD, WY), we’ll automatically send you an at-home collection kit for no charge.

All medications carry a risk of potential side effects. Wegovy’s side effects are typically mild and often improve within the first few weeks of treatment. When they occur, it’s usually when doses are increased, then tend to improve once a steady dose is reached. Some of the most common side effects include:

  • Nausea

  • Vomiting

  • Upset stomach

  • Stomach pains

  • Constipation

  • Diarrhea

  • Heartburn

  • Acid reflux

  • Belching and gas

  • Dizziness

  • Headaches

  • Fatigue

More severe side effects are rarer but possible. Serious side effects include:

  • Thyroid cancer—The FDA has issued its most serious warning (called a BOXED WARNING) that GLP-1s may be associated with a type of thyroid cancer called medullary thyroid carcinoma. So far, this side effect has primarily been seen in laboratory studies using rodents, so the risk to humans has not been determined.

  • Pancreatitis

  • Gallbladder disease

  • Rapid heartbeat

  • Severe allergy (hypersensitivity)

  • Low blood sugar

  • Vision problems (diabetic retinopathy)

  • Kidney disease

  • Suicidal thoughts or behaviors

Please see the full Prescribing Information, including the BOXED WARNING, for complete safety information.

We hear all the time that weight loss depends on willpower. And that’s just not true. Obesity is a disease, not a decision. Being overweight is about the biology of your body. There are steps that you can take to put science on your side. And we know how.

From experts at Ro

Read more about GLP-1s

  • 6 min read

    How to take Wegovy?

  • 7 min read

    Wegovy or Ozempic for weight loss?

  • 7 min read

    Wegovy shortage alternatives

Important safety information

What you should know before taking Wegovy.

Dr Steve Silvestro, Ro

Wegovy 101

What is Wegovy?

Wegovy is a brand-name version of the generic medication semaglutide, which is a type of medication called a glucagon-like peptide 1 receptor agonist. Instead of that tongue-twister of a name, we call these medications “GLP-1s” for short. Wegovy is FDA-approved and clinically proven to help with weight loss. How? It acts like a natural hormone your body uses to regulate blood sugar and appetite—key steps in resetting your biological set point to help you maintain a new, lower weight. In fact, in the pivotal clinical trial people who combined Wegovy with lifestyle changes lost an average of 9% of their body weight after 20 weeks, and 14.9% after 68 weeks. Learn more about Wegovy and weight loss.


How does Wegovy work?

Wegovy works by mimicking the hormone GLP-1, which slows digestion and helps your brain regulate appetite by reducing hunger sensations. As your digestion slows, you may feel full longer and therefore eat less, which can lead to weight loss.


What is Wegovy’s dosing?

Wegovy dosing starts out low, then gradually increases over the first few months until a steady dose is reached. If prescribed, your Ro-affiliated provider will work with you to find the schedule and dosing that’s right for you. As an example, your provider may start you out on the lowest dose, 0.25 mg injected once weekly for the first month and slowly ramp you up to the maximum dose of 2.4 mg once weekly over the course of several months. This will depend upon your specific situation and your provider’s guidance.


How do you take Wegovy?

Wegovy comes in a prefilled injection pen. If prescribed, you (or someone in your household) will administer the injection under the skin of your stomach, thigh, or arm once a week. While a routine injection may sound intimidating, the Wegovy pen uses a tiny needle designed to minimize discomfort. You’ll also receive clear instructions on using the injection pen, and your Ro-affiliated provider can offer additional advice.


How much weight can I expect to lose with GLP-1s?

In clinical trials, patients lost 15% of their body weight after 1 year, on average. This is based on the average weight loss in the three 68-week clinical trials of patients without diabetes who reached and maintained a dose of 2.4 mg/week of GLP-1 treatment, along with a reduced-calorie diet and increased physical activity.


How quickly do people lose weight with Wegovy?

In the STEP 4 clinical trial, people who combined Wegovy with a healthy diet and exercise lost an average of over 4% of their body weight by eight weeks. Those who reached a steady dose of 2.4 mg per week lost an average of 10.6% of their body weight in the first 20 weeks of treatment—and over 17% of their body weight within 68 weeks. Everyone responds to Wegovy differently, and if prescribed, your Ro-affiliated provider will work with you to get the best results for you. See if Wegovy is right for you here.